Preparation, characterization, and in vitro/vivo evaluation of a multifunctional electrode coating for cochlear implants

• Published in: Biomaterials advances 2024-02, Vol.157, p.213736-213736, Article 213736
• Main Authors: Xu, Muqing, Chen, Anning, Chen, Dongxiu, Wu, Shengquan, Deng, Zhipeng, Wen, Hang, Zhong, Huiling, Lu, Kejin, Tang, Jie, Ma, Dong, Zhang, Hongzheng
• Format: Article
• Language: English
• ISSN: 2772-9508; 2772-9508
• DOI: 10.1016/j.bioadv.2023.213736

Cochlear implantation (CI) is the primary intervention for patients with sensorineural hearing loss to restore their hearing. However, approximately 90 % of CI recipients experience unexpected fibrosis around the inserted electrode arrays due to acute and chronic inflammation. This fibrosis leads to progressive residual hearing loss. Addressing this complication is crucial for enhancing CI outcomes, yet an effective treatment has not yet been found. In this study, we developed a multifunctional dexamethasone (DXM)-loaded polytrimethylene carbonate (PTMC) electrode coating to mitigate inflammatory reactions and fibrosis after CI. This thin and flexible coating could preserve the mechanical performance of the electrode and reduce the implantation resistance for CI. The in vitro release studies demonstrated the DXM-PTMC coating's efficient drug loading and sustained release capability over 90 days. DXM-PTMC also showed long-term stability, high biocompatibility, and effective anti-inflammatory effects in vitro and in vivo. Compared with the uncoated group, DXM-PTMC coating significantly inhibited the expression of inflammatory factors, such as NO, TNF-α, IL-1β, and IL-6. DXM-PTMC coating suppressed fibrosis in rat implantation models for 3 weeks by reducing both acute and chronic inflammation. Our findings suggest that DXM-PTMC coating is a novel strategy to improve the outcomes of CI.